This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday – Ligand Pharmaceuticals (NASDAQ:LGND), MannKind (NASDAQ:MNKD)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• B of A Securities analyst Joshua Dennerlein initiated coverage on MSCI Inc. MSCI with a Neutral rating and announced a price target of $585. MSCI shares closed at $549.33 on Wednesday. See how other analysts view this stock.
• Mizuho initiated coverage on MannKind Corporation MNKD with an Outperform rating and announced a price target of $12. MannKind shares closed at $4.69 on Wednesday. See how other analysts view this stock.
• Jefferies analyst Kelly Shi initiated coverage on Verastem, Inc. VSTM with a Buy rating and announced a price target of $15. Verastem shares closed at $5.28 on Wednesday. See how other analysts view this stock.
• JP Morgan analyst Tami Zakaria initiated coverage on Westinghouse Air Brake Technologies Corporation WAB with a Neutral rating and announces Price Target of $175. Westinghouse Air Brake shares closed at $175.82 on Wednesday. See how other analysts view this stock.
• Stifel analyst Annabel Samimy initiated coverage on Ligand Pharmaceuticals Incorporated LGND with a Buy rating and announced a price target of $143. Ligand Pharmaceuticals shares closed at $103.85 on Wednesday.  See how other analysts view this stock.

Considering buying LGND stock? Here’s what analysts think:

Read This Next:

• Top 2 Materials Stocks That May Fall Off A Cliff This Quarter

Photo via Shutterstock